JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2005; 46:2204-2207, doi:10.1016/j.jacc.2005.08.034
© 2005 by the American College of Cardiology Foundation
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Daubert, J. C.
Right arrow Articles by Mabo, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Daubert, J. C.
Right arrow Articles by Mabo, P.

VIEWPOINT AND COMMENTARY

There Is Plenty of Room for Cardiac Resynchronization Therapy Devices Without Back-Up Defibrillators in the Electrical Treatment of Heart Failure

J. Claude Daubert, MD, FACC*, Christophe Leclercq, MD, PhD and Philippe Mabo, MD

Department of Cardiology, Centre Hospitalier Universitaire, Rennes, France

Manuscript received August 4, 2005; accepted August 9, 2005.

* Reprint requests and correspondence: Dr. Jean-Claude Daubert, Centre Hospitalier Universitaire, Department of Cardiology, F-35000 Rennes, France. (Email: jean-claude.daubert{at}chu-rennes.fr).

Patients with chronic heart failure might benefit from electrical therapy with a view to resynchronize the heart and improve its mechanical performance by cardiac resynchronization therapy (CRT) or to prevent the risk of sudden death by automatic defibrillation. These two therapies can be applied separately or with a combined device, the biventricular implantable cardioverter-defibrillator (CRT-D). There is currently no strong scientific evidence indicating that a CRT-D must be offered to all candidates for CRT. Plain common sense should limit the prescription of these costly devices for patients in need of secondary prevention or for younger patients without major comorbidities. The preferential choice of CRT pacemakers in the remainder of patients is currently a logical one.

Abbreviations and Acronyms
  ARR = absolute risk reduction
  CHF = chronic heart failure
  CRT-D = cardiac resynchronization therapy by biventricular defibrillation
  CRT-P = pacemaker for cardiac resynchronization therapy
  EF = ejection fraction
  ICD = implantable cardioverter-defibrillator
  LV = left ventricular
  NYHA = New York Heart Association
  RRR = relative reduction in the risk of overall mortality




This article has been cited by other articles:


Home page
CirculationHome page
O.-A. Breithardt and G. Breithardt
Quest for the Best Candidate: How Much Imaging Do We Need Before Prescribing Cardiac Resynchronization Therapy?
Circulation, February 21, 2006; 113(7): 926 - 928.
[Full Text] [PDF]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2005 by the American College of Cardiology Foundation.